Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 378

1.

A bio-inspired glucose controller based on pancreatic β-cell physiology.

Herrero P, Georgiou P, Oliver N, Johnston DG, Toumazou C.

J Diabetes Sci Technol. 2012 May 1;6(3):606-16.

2.

Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.

Clarke WL, Anderson S, Breton M, Patek S, Kashmer L, Kovatchev B.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1031-8.

3.

Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies.

Wilinska ME, Budiman ES, Taub MB, Elleri D, Allen JM, Acerini CL, Dunger DB, Hovorka R.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1109-20.

4.

Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier.

Bruttomesso D, Farret A, Costa S, Marescotti MC, Vettore M, Avogaro A, Tiengo A, Dalla Man C, Place J, Facchinetti A, Guerra S, Magni L, De Nicolao G, Cobelli C, Renard E, Maran A.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1014-21.

5.

Control to range for diabetes: functionality and modular architecture.

Kovatchev B, Patek S, Dassau E, Doyle FJ 3rd, Magni L, De Nicolao G, Cobelli C; Juvenile Diabetes Research Foundation Artificial Pancreas Consortium.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1058-65.

6.

Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results.

Kovatchev B, Cobelli C, Renard E, Anderson S, Breton M, Patek S, Clarke W, Bruttomesso D, Maran A, Costa S, Avogaro A, Dalla Man C, Facchinetti A, Magni L, De Nicolao G, Place J, Farret A.

J Diabetes Sci Technol. 2010 Nov 1;4(6):1374-81.

7.

Experimental evaluation of a recursive model identification technique for type 1 diabetes.

Finan DA, Doyle FJ 3rd, Palerm CC, Bevier WC, Zisser HC, Jovanovic L, Seborg DE.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1192-202.

8.

An integrated multivariable artificial pancreas control system.

Turksoy K, Quinn LT, Littlejohn E, Cinar A.

J Diabetes Sci Technol. 2014 May;8(3):498-507. doi: 10.1177/1932296814524862. Epub 2014 Apr 7.

9.

A closed-loop artificial pancreas using model predictive control and a sliding meal size estimator.

Lee H, Buckingham BA, Wilson DM, Bequette BW.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1082-90.

10.

A novel adaptive basal therapy based on the value and rate of change of blood glucose.

Wang Y, Percival MW, Dassau E, Zisser HC, Jovanovic L, Doyle FJ 3rd.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1099-108.

11.

The PILGRIM study: in silico modeling of a predictive low glucose management system and feasibility in youth with type 1 diabetes during exercise.

Danne T, Tsioli C, Kordonouri O, Blaesig S, Remus K, Roy A, Keenan B, Lee SW, Kaufman FR.

Diabetes Technol Ther. 2014 Jun;16(6):338-47. doi: 10.1089/dia.2013.0327. Epub 2014 Jan 21.

PMID:
24447074
12.

Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events.

Grosman B, Dassau E, Zisser HC, Jovanovic L, Doyle FJ 3rd.

J Diabetes Sci Technol. 2010 Jul 1;4(4):961-75.

13.
14.

Run-to-run tuning of model predictive control for type 1 diabetes subjects: in silico trial.

Magni L, Forgione M, Toffanin C, Dalla Man C, Kovatchev B, De Nicolao G, Cobelli C.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1091-8.

15.

Glucose clamp algorithms and insulin time-action profiles.

Bequette BW.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1005-13. Review.

16.

Factors influencing the effectiveness of glucagon for preventing hypoglycemia.

Castle JR, Engle JM, El Youssef J, Massoud RG, Ward WK.

J Diabetes Sci Technol. 2010 Nov 1;4(6):1305-10.

17.

Identification of intraday metabolic profiles during closed-loop glucose control in individuals with type 1 diabetes.

Kanderian SS, Weinzimer S, Voskanyan G, Steil GM.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1047-57.

18.

Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.

Haidar A, Legault L, Dallaire M, Alkhateeb A, Coriati A, Messier V, Cheng P, Millette M, Boulet B, Rabasa-Lhoret R.

CMAJ. 2013 Mar 5;185(4):297-305. doi: 10.1503/cmaj.121265. Epub 2013 Jan 28.

19.

Clinical evaluation of an automated artificial pancreas using zone-model predictive control and health monitoring system.

Harvey RA, Dassau E, Bevier WC, Seborg DE, Jovanovič L, Doyle FJ 3rd, Zisser HC.

Diabetes Technol Ther. 2014 Jun;16(6):348-57. doi: 10.1089/dia.2013.0231. Epub 2014 Jan 28.

20.

A benchtop closed-loop system controlled by a bio-inspired silicon implementation of the pancreatic beta cell.

Oliver N, Georgiou P, Johnston D, Toumazou C.

J Diabetes Sci Technol. 2009 Nov 1;3(6):1419-24.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk